Retraction Note: METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2
- PMID: 35916787
- DOI: 10.26355/eurrev_202207_29277
Retraction Note: METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2
Abstract
The article "METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2, by Q.-Z. Meng, C.-H. Cong, X.-J. Li, F. Zhu, X. Zhao, F.-W. Chen, published in Eur Rev Med Pharmacol Sci 2020; 24 (8): 4328-4336-DOI: 10.26355/eurrev_202004_21014-PMID: 32373970" has been retracted by the authors. After publication, several issues were raised on PubPeer about the reliability of the published results. The same authors stated that the study was not performed in accordance with the standard procedures required. In particular, Figure 1 also presents some concerns as it does not reflect the experimental data reported in the study. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/21014.
Retraction of
-
METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2.Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4328-4336. doi: 10.26355/eurrev_202004_21014. Eur Rev Med Pharmacol Sci. 2020. Retraction in: Eur Rev Med Pharmacol Sci. 2022 Jul;26(14):4947. doi: 10.26355/eurrev_202207_29277. PMID: 32373970 Retracted.
Similar articles
-
Retraction Note: Salinomycin enhances radiotherapy sensitivity and reduces expressions of BIRC5 and NEIL2 in nasopharyngeal carcinoma.Eur Rev Med Pharmacol Sci. 2022 Sep;26(17):6012. doi: 10.26355/eurrev_202209_29611. Eur Rev Med Pharmacol Sci. 2022. PMID: 36111899
-
Retraction Note: MiRNA-215-5p alleviates the metastasis of prostate cancer by targeting PGK1.Eur Rev Med Pharmacol Sci. 2024 May;28(10):3476. doi: 10.26355/eurrev_202405_36279. Eur Rev Med Pharmacol Sci. 2024. PMID: 38856147
-
Retraction Note: Effect of atorvastatin on pulmonary arterial hypertension in rats through PI3K/AKT signaling pathway.Eur Rev Med Pharmacol Sci. 2023 Sep;27(17):7881. doi: 10.26355/eurrev_202309_33543. Eur Rev Med Pharmacol Sci. 2023. PMID: 37750615
-
Retraction Note: Role of long non-coding RNA SNHG1 in occurrence and progression of ovarian carcinoma.Eur Rev Med Pharmacol Sci. 2022 Sep;26(17):6013. doi: 10.26355/eurrev_202209_29614. Eur Rev Med Pharmacol Sci. 2022. PMID: 36111900
-
Retraction Note: MicroRNA-199a regulates myocardial fibrosis in rats by targeting SFRP5.Eur Rev Med Pharmacol Sci. 2024 Apr;28(7):2631. doi: 10.26355/eurrev_202404_35935. Eur Rev Med Pharmacol Sci. 2024. PMID: 38639499
Publication types
LinkOut - more resources
Full Text Sources
